Laboratory diagnosis and characteristics of breakthrough varicella in children

Journal of Infectious Diseases

Volumn 197, Issue SUPPL. 2, 2008, Pages

  Weinmann, Sheila ^a   Chun, Colleen ^a   Mullooly, John P ^a   Riedlinger, Karen ^a   Houston, Heather ^a   Loparev, Vladimir N ^c   Schmid, D Scott ^b   Seward, Jane F ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c Centers for Disease Control and Prevention   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

BLOOD SAMPLING; CHICKENPOX; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA EXTRACTION; DNA PURIFICATION; FEMALE; HUMAN; INFANT; LABORATORY DIAGNOSIS; MALE; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROLOGY; VARICELLA ZOSTER VIRUS; VIRUS IDENTIFICATION;

ACUTE DISEASE; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; CONVALESCENCE; DNA, VIRAL; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; MALE; POLYMERASE CHAIN REACTION; VACCINATION;

EID: 42549120243     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522148     Document Type: Conference Paper

References (28)

1. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287:606-11.
2. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114:786-92.
3. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005; 294:797-802.
4. Nguyen H, Jumaan AO, Seward JF. Decline in varicella mortality after introduction of varicella vaccine in the United States. N Engl J Med 2005; 352:450-8.
5. Asano Y, Suga S, Yoshikawa T, et al. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 1994; 94:524-6.
6. White CJ, Kuter BJ, Ngai A, et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J 1992; 11:19-23.
7. Black S, Shinefield H, Ray P, Nikas A, Saddier P. Are varicella breakthrough rates dependent on age of vaccination? [abstract 1800]. In: Program and abstracts of the Pediatric Academic Societies' Annual Meeting (San Francisco). The Woodlands, TX: Pediatric Academic Societies, 2004.
8. Vazquez M, LaRussa PS, Gershon AA, et al. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 2001; 344:955-60.
9. Watson B, Piercy SA, Plotkin SA, Starr SE. Modified Chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993; 91:17-22.
10. Bernstein HH, Rothstein EP, Pennridge Pediatric Associates, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics 1993; 92:833-7.
11. Centers for Disease Control and Prevention. Outbreak of varicella among vaccinated children - Michigan, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:389-91.
12. Galil K, Fair E, Mountcastle N, et al. Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis 2002; 186:102-5.
13. Vazquez M, LaRussa PS, Gershon AA, et al. The effectiveness over time of varicella vaccine. JAMA 2004; 291:851-5.
14. Mullooly JP, Maher JE, Drew L, Schuler R, Hu W. Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella. Vaccine 2004; 22:1480-5.
15. Making an informed choice with 1997 HEDIS 3.0 performance measures, Northwest. Portland: Kaiser Permanente Northwest, 1998.
16. Making an informed choice with HEDIS 2000 performance measures, Northwest. Portland: Kaiser Permanente Northwest, 2000.
17. Wasmuth EH, Miller WJ. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol 1990; 32:189-93.
18. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol 2000; 38:4315-9.
19. Yoshida M, Tamura T, Hiruma M. Analysis of strain variation of R1 repeated structure in varicella-zoster virus DNA by polymerase chain reaction. J Med Virol 1999; 58:76-8.
20. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. Restriction fragment polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992; 66:1016-20.
21. Vazquez M, Shapiro E, LaRussa PS. Response to "The effectiveness of varicella vaccine" [letter]. N Engl J Med 2001; 345:464-5.
22. Watson B, Perella D, Heath K, et al. Laboratory confirmation of suspected breakthrough varicella infections [abstract 1927]. In: Program and abstracts of the Pediatric Academic Societies' Annual Meeting (San Francisco). The Woodlands, TX: Pediatric Academic Societies, 2004.
23. Hidaka Y, Aoki T, Akeda H, Miyazaki C, Ueda K. Serological and clinical characteristics of measles vaccine failure in Japan. Scand J Infect Dis 1994; 26:725-30.
24. Dangel V, Bader U, Enders G. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples. J Clin Virol 2006; 35:303-9.
25. Loparev VN, Argaw T, Krause PR, Takayama M, Schmid DS. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol 2000; 38:3156-60.
26. Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 2004; 23:132-7.
27. Vessey SJR, Chan CY, Kuter BJ, et al. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy. J Pediatr 2001; 139:297-304.
28. Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. JAMA 2004; 292:704-8.